Author:
Camidge D. Ross,Doebele Robert C.
Publisher
Springer Science and Business Media LLC
Reference99 articles.
1. Le Beau, M. M. et al. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki1positive anaplastic large cell lymphoma. Leukemia 3, 866–870 (1989).
2. Morris, S. W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281–1284 (1994).
3. Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448, 561–566 (2007).
4. Kwak, E. L. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363, 1693–1703 (2010).
5. Crinò, L. et al. Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005 [abstract]. J. Clin. Oncol. 29 (Suppl.), a7514 (2011).
Cited by
214 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献